Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,325 | -12,521 | N/A | N/A | N/A |
| Depreciation Amortization | 450 | 214 | N/A | N/A | N/A |
| Other Working Capital | -1,105 | 1,093 | N/A | N/A | N/A |
| Other Operating Activity | 1,925 | 250 | 0 | 0 | 0 |
| Operating Cash Flow | $-31,055 | $-10,964 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,634 | -925 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,634 | $-925 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 152,227 | 19 | N/A | N/A | N/A |
| Other Financing Activity | -2,465 | 115,620 | 0 | 0 | 0 |
| Financing Cash Flow | $149,762 | $115,639 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 105,603 | 1,853 | N/A | N/A | N/A |
| End Cash Position | 222,676 | 105,603 | N/A | N/A | N/A |
| Net Cash Flow | $117,073 | $103,750 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,055 | -10,964 | N/A | N/A | N/A |
| Capital Expenditure | -1,635 | -935 | N/A | N/A | N/A |
| Free Cash Flow | -32,690 | -11,899 | 0 | 0 | 0 |